1. Home
  2. COEP vs HLP Comparison

COEP vs HLP Comparison

Compare COEP & HLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • HLP
  • Stock Information
  • Founded
  • COEP 2017
  • HLP 2021
  • Country
  • COEP United States
  • HLP China
  • Employees
  • COEP N/A
  • HLP N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • HLP Industrial Machinery/Components
  • Sector
  • COEP Health Care
  • HLP Industrials
  • Exchange
  • COEP Nasdaq
  • HLP Nasdaq
  • Market Cap
  • COEP 86.0M
  • HLP 102.1M
  • IPO Year
  • COEP N/A
  • HLP 2023
  • Fundamental
  • Price
  • COEP $15.29
  • HLP N/A
  • Analyst Decision
  • COEP
  • HLP
  • Analyst Count
  • COEP 0
  • HLP 0
  • Target Price
  • COEP N/A
  • HLP N/A
  • AVG Volume (30 Days)
  • COEP 66.5K
  • HLP 317.2K
  • Earning Date
  • COEP 11-12-2025
  • HLP 09-19-2025
  • Dividend Yield
  • COEP N/A
  • HLP N/A
  • EPS Growth
  • COEP N/A
  • HLP N/A
  • EPS
  • COEP N/A
  • HLP 0.02
  • Revenue
  • COEP $263,555.00
  • HLP $16,731,357.00
  • Revenue This Year
  • COEP N/A
  • HLP N/A
  • Revenue Next Year
  • COEP N/A
  • HLP N/A
  • P/E Ratio
  • COEP N/A
  • HLP $71.04
  • Revenue Growth
  • COEP N/A
  • HLP 19.13
  • 52 Week Low
  • COEP $2.31
  • HLP $0.61
  • 52 Week High
  • COEP $19.19
  • HLP $1.82
  • Technical
  • Relative Strength Index (RSI)
  • COEP 49.85
  • HLP 64.67
  • Support Level
  • COEP $14.90
  • HLP $1.34
  • Resistance Level
  • COEP $16.17
  • HLP $1.69
  • Average True Range (ATR)
  • COEP 1.17
  • HLP 0.19
  • MACD
  • COEP -0.30
  • HLP 0.00
  • Stochastic Oscillator
  • COEP 11.94
  • HLP 69.70

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About HLP Hongli Group Inc.

Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.

Share on Social Networks: